According to MarketsandMarkets™, The global Digital PCR (dPCR) and Real-time PCR (qPCR) market is projected to grow from USD 10.0 billion in 2024 to USD 14.8 billion by 2029, at a CAGR of 8.1% during the forecast period. Market growth is fueled by the increasing adoption of PCR technologies in point-of-care diagnostics, continuous technological advancements, and the rising importance of PCR in biomarker discovery.
Browse 907 market data Tables and 58 Figures spread through 598 Pages and in-depth TOC on “Digital PCR (dPCR) and Real-time PCR (qPCR) Market “.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
The growing need for precise, rapid, and sensitive diagnostic tools—particularly in infectious diseases and oncology—is accelerating the use of dPCR and qPCR technologies across clinical and research settings. However, challenges such as unfavorable reimbursement scenarios and certain technical limitations associated with PCR technologies may restrain market growth.
Product Segment Leads Market Growth
Based on offering, the product segment—which includes reagents & consumables and instruments—accounted for the largest share of the market in 2023 and is expected to maintain its dominance during the forecast period.
The strong growth of this segment is driven by increasing demand for accurate genomic analysis and ongoing advancements in biotechnology that enhance reagent quality and assay performance. Additionally, qPCR and dPCR instruments are expected to witness significant growth due to improvements in sensitivity, throughput, and automation, as well as their expanding use in both clinical diagnostics and life science research.
Clinical Applications Segment to Register Highest Growth
By application, the clinical segment is projected to account for the largest share of the market during the forecast period. The increasing use of PCR technologies in disease diagnosis, particularly for infectious diseases and cancer, is a key growth driver.
Rising prevalence of chronic and infectious diseases, coupled with the growing demand for early and accurate diagnosis, is further boosting adoption. Despite this, limited reimbursement coverage in certain regions and the availability of alternative diagnostic methods may pose challenges to widespread adoption.
Asia Pacific Emerges as Fastest-Growing Region
The Asia Pacific region is expected to register the highest growth rate in the Digital PCR (dPCR) and Real-time PCR (qPCR) market during the forecast period. Growth in this region is driven by increasing incidences of infectious diseases, rising investments by biopharmaceutical companies and contract manufacturing organizations (CMOs), and a growing focus on strengthening healthcare infrastructure.
Additionally, the expanding presence of diagnostic laboratories and increased demand for advanced molecular diagnostic solutions are contributing to the rapid adoption of PCR technologies across emerging economies in the region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174151204
Competitive Landscape
Key players operating in the Digital PCR (dPCR) and Real-time PCR (qPCR) market include Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen N.V. (Germany), Abbott Laboratories (US), bioMérieux (France), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Eppendorf AG (Germany), Bio-Rad Laboratories, Inc. (US), Takara Bio Inc. (Japan), Promega Corporation (US), Meridian Bioscience, Inc. (US), Endress+Hauser (Switzerland), QuidelOrtho Corporation (US), Lepu Medical Technology (China), Sysmex Corporation (Japan), and Enzo Biochem, Inc. (US).
These companies are focusing on innovation, strategic partnerships, and product portfolio expansion to strengthen their market position and address the growing demand for advanced molecular diagnostic solutions.
Related Reports:
Next-generation Sequencing Market – Global Forecast to 2031
Genomics Market – Global Forecast to 2030
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market-174151204.html
